YR1143
科研级 Racotumomab ( 雷妥莫单抗 ), Anti-Idiotope of Anti-(NGNA-Gangliosides GM3) Mouse P3 IgM-kappa Monoclonal Antibody Recombinant Antibody, Research Grade Racotumomab
| Alias | 科研级 Racotumomab ( 雷妥莫单抗 ), Anti-Idiotope of Anti-(NGNA-Gangliosides GM3) Mouse P3 IgM-kappa Monoclonal Antibody Recombinant Antibody, Research Grade Racotumomab |
| Catalog Number | YR1143 |
| Molecular Name | Racotumomab |
| Host | Mouse |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 Kappa |
| Formulation | PBS, pH7.5 |
| Background | Racotumomab (trade name Vaxira) is a therapeutic cancer vaccine for the treatment of solid tumors that is currently under clinical development by Recombio, an international public-private consortium with the participation of the Center of Molecular Immunology at Havana, Cuba (CIM) and researchers from Buenos Aires University and National University of Quilmes in Argentina. |
| CAS Number | 946832-34-4 |
| Application | FCM, IP, ELISA, Neut, FuncS, IF |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | Idiotope of Anti-(NGNA-Gangliosides GM3) Mouse P3 IgM-kappa Monoclonal Antibody[Homo sapiens] |
Service Account
0
